Male Breast Cancer News and Research

Breast cancer survivors at higher risk of developing second cancers

Survivors of breast cancer are at significantly higher risk of developing second cancers, including endometrial and ovarian cancer for women and prostate cancer for men, according to new research studying data from almost 600,000 patients in England.

What was the prevalence of germline genetic testing among patients diagnosed with cancer in California and Georgia between 2013 and 2019?

Researchers performed an observational study to determine the prevalence of germline genetic testing among all patients aged 20 years or older diagnosed with cancer between January 1, 2013, and March 31, 2019, in two United States, California and Georgia.

Adequate radiation protection could help prevent breast cancer in female healthcare workers

Women working in healthcare who are regularly exposed to radiation from x-rays and other imaging procedures need better ionizing radiation protection to help minimize their risk of developing breast cancer, argue doctors in The BMJ today.

Cedars Sinai experts remind men of their breast cancer risk

Although breast cancer is more common in women, during October, Breast Cancer Awareness Month, experts from Cedars-Sinai Cancer are reminding men that they are at risk as well. One in every 100 breast cancers in the U.S. is diagnosed in a man, according to the Centers for Disease Control and Prevention.

Celebrating 10 Years of Global Research with Breast Cancer Now Tissue Bank

Breast Cancer Now Tissue Bank have just celebrated 10 years of groundbreaking breast cancer research. We spoke to Professor Louise Jones to find out more about this achievement!

Men with Stage IV breast cancer who are receptive to systemic therapy benefit from surgery

Men with Stage IV breast cancer and known estrogen (ER) and progesterone receptor (PR) status benefit from surgical intervention and from trimodal therapy (systemic therapy, surgery, and radiation), according to a study presented at the virtual American College of Surgeons (ACS) Clinical Congress 2021.

Study finds high prevalence of cardiovascular conditions in male breast cancer patients

Male breast cancer patients were found to have a high prevalence of cardiovascular conditions, in a small study of this rare patient population presented at the American College of Cardiology's Advancing the Cardiovascular Care of the Oncology Patient Virtual course.

Study shows gender differences in prognosis predictive utility of breast cancer recurrence score

The TAILORx study published last year offered good news for women with early-stage ER-positive breast cancer who scored at intermediate risk for recurrence according to a genetic assay test.

Men with breast cancer more likely to die than women, study finds

Men with breast cancer are more likely to die than their female counterparts, across all stages of disease, with the disparity persisting even when clinical characteristics, such as cancer types, treatment and access to care are considered, according to a study by Vanderbilt researchers published in JAMA Oncology.

Study highlights practice patterns and factors associated with prognosis of male breast cancer

A recent analysis reveals that treatment of male breast cancer has evolved over the years. In addition, certain patient-, tumor-, and treatment-related factors are linked with better survival. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society.

Understanding treatment and prognosis of male breast cancer

October is Breast Cancer Awareness Month, an annual campaign to raise awareness about the potentially-fatal disease. Breast cancer is known as an illness that affects mostly women, but about 1 percent of all breast cancers affect men, too.

Multi-gene testing at point of diagnosis can save all women with breast cancer

A lifetime model evaluating the financial, health and social impact of multi-gene testing (BRCA1/2/PALB2) at diagnosis for all breast cancer patients was found to be extremely cost effective for both UK and US health systems.

FDA extends indication of metastatic breast cancer treatment to include male patients

The U.S. Food and Drug Administration today is extending the indication of Ibrance (palbociclib) capsules in combination with specific endocrine therapies for hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in male patients.

Drugs approved for breast cancer treatment are effective and well tolerated in men

There is growing evidence that drugs approved for the treatment of breast cancer in women are also effective and well tolerated in men, according to the largest real-life study yet to investigate treatment and outcomes in men with breast cancer and two further studies to be reported at ESMO 2018.

Breast cancer cases among men who were at ground zero on 9/11

The after effects of the terror attacks on 11th September 2001 in the United States are still appearing. Around 15 men who were present near the Ground Zero on the fateful day have been diagnosed with rare forms of male breast cancer. Male breast cancer makes up for less than 1 percent of all breast cancers. 

This new data emerges from a client list of a law firm that is specially looking into health cases of those in and around the region on 9/11. There could be many more men who are outside of this data base say experts. Two of the men – Jeff Flynn (65 years old) and John Mormando (51 years old) who were near the zone were initially diagnosed with the cancer and are being treated for it. Both men say that there is no history of breast cancers in their family and they were exposed to toxins on the day.

Flynn was an account manager for a data-storage company Dell EMC and was assigned to Goldman Sachs on Maiden Lane on the fateful day. He was around the region for months after the attack helping Goldman and other financial services firms to set up again.

After a decade, in 2011, he first noticed an abnormality in one of his nipples and was then diagnosed with stage 3 breast cancer for which he underwent extensive operations. Soon the cancer returned as a stage 4 cancer. He was awarded compensation from the September 11th Victim Compensation Fund that helped him pay for his treatment. Mormando was a commodities broker working at the Mercantile Exchange until 2007. He is a triathlete now. Last year he noticed a lump on his chest and was diagnosed with the breast cancer.

Leon Silverstein (89 years old), an Army veteran, was diagnosed with breast cancer and had to be operated upon. As a result of the cancer both his breasts had to be removed in a double mastectomy. He used to live near Battery Park near the Ground Zero for 30 years.

Experts believe that apart from those killed during the attacks more people are emerging with long term after effects of the attack. There are over ten thousand individuals who were members of the first responders’ teams for rescue operations or were near the region when the attack took place.

These people have been diagnosed with various forms of cancers due to exposure to the toxins. Over 2000 individuals have ailments that can be attributed to the toxins on that day. The Chief of the fire Department of New York, for example, who was leading the first responder efforts died this June from cancer.

Men's Health Week

A series of articles for Men's Health Week 2018.

Liposuction to manage lymphedema? An interview with Professor John Boyages

Lymphedema is persistent swelling of the arm and/or hand following biopsy or treatment of the axillary lymph nodes for patients with breast cancer. It is due to excess accumulation of protein‐rich fluid in body tissues.

Research uncovers biological differences between male, female breast cancers

Male breast cancer (Male BC) has important biological differences that distinguish it from female breast cancer, but to date these have been little studied and Male BC patients have been excluded from many clinical trials in breast cancer.

More men with breast cancer are opting for double mastectomy

The number of men with invasive cancer in one breast who undergo surgery to remove both breasts is on the rise, according to a new report published in JAMA Surgery.

NeoGenomics announces launch of new germline cancer predisposition testing services

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, announced today the launch of a new line of germline cancer predisposition testing services. The new tests include comprehensive testing for BRCA1 and BRCA2 encompassing an analysis of all exons and adjacent intronic regions.